US industry turns its sights on Medicare reform
This article was originally published in Clinica
Executive Summary
Now that the FDA has been turned upside down - with user fees and restructuring taking up much of 2002 - the devices industry is free to turn its attention to a host of other issues that were largely put on hold last year.